Found: 42
Select item for more details and to access through your institution.
<sup>18</sup>F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267186
- By:
- Publication type:
- Article
First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266392
- By:
- Publication type:
- Article
Nuclear-Based Labeling of Cellular Immunotherapies: A Simple Protocol for Preclinical Use.
- Published in:
- Molecular Imaging & Biology, 2024, v. 26, n. 4, p. 555, doi. 10.1007/s11307-024-01923-z
- By:
- Publication type:
- Article
First in-human evaluation of [1-<sup>13</sup>C]pyruvate in D<sub>2</sub>O for hyperpolarized MRI of the brain: A safety and feasibility study.
- Published in:
- Magnetic Resonance in Medicine, 2024, v. 91, n. 6, p. 2559, doi. 10.1002/mrm.30002
- By:
- Publication type:
- Article
Good practices for <sup>89</sup>Zr radiopharmaceutical production and quality control.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 9, n. 1, p. 1, doi. 10.1186/s41181-024-00258-y
- By:
- Publication type:
- Article
<sup>18</sup>F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 5, p. 722, doi. 10.2967/jnumed.123.267186
- By:
- Publication type:
- Article
First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 386, doi. 10.2967/jnumed.123.266392
- By:
- Publication type:
- Article
First-in-Human Evaluation of Site-Specifically Labeled <sup>89</sup>Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.266392
- By:
- Publication type:
- Article
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00230-2
- By:
- Publication type:
- Article
Noninvasive Assessment of Human Epidermal Growth Factor Receptor 2 (HER2) in Esophagogastric Cancer Using <sup>89</sup>Zr-Trastuzumab PET: A Pilot Study.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 724, doi. 10.2967/jnumed.122.264470
- By:
- Publication type:
- Article
Phase 1 study of intraventricular <sup>131</sup>I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01383-4
- By:
- Publication type:
- Article
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2022, v. 7, n. 1, p. 1, doi. 10.1186/s41181-022-00168-x
- By:
- Publication type:
- Article
Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 13, p. 3047, doi. 10.1007/s00259-020-04832-9
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
Imaging metastatic castration-resistant prostate cancer patients with <sup>89</sup>Zr-DFO-MSTP2109A anti-STEAP1 antibody.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.222844
- By:
- Publication type:
- Article
Biodistribution and Dosimetry of Intraventricularly Administered 124I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.219576
- By:
- Publication type:
- Article
First-in-human imaging with <sup>89</sup>Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.229781
- By:
- Publication type:
- Article
Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using <sup>89</sup>Zr-DFO-MSTP2109A Anti-STEAP1 Antibody.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 11, p. 1517, doi. 10.2967/jnumed.118.222844
- By:
- Publication type:
- Article
Synthesis, preclinical analysis, and first-in-human phase I imaging of 89Zr-DFO-daratumumab for CD38 targeted imaging of myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e19, doi. 10.1016/j.clml.2019.09.027
- By:
- Publication type:
- Article
Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 506, p. 1, doi. 10.1126/scitranslmed.aaw7736
- By:
- Publication type:
- Article
Biodistribution and radiation dose estimates for <sup>68</sup>Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 3, p. 677, doi. 10.1007/s00259-018-4193-y
- By:
- Publication type:
- Article
Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 10, p. 1516, doi. 10.2967/jnumed.117.206490
- By:
- Publication type:
- Article
First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 6, p. 900, doi. 10.2967/jnumed.117.202010
- By:
- Publication type:
- Article
I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 0, doi. 10.1186/s13550-018-0374-8
- By:
- Publication type:
- Article
Biodistribution and Dosimetry of <sup>18</sup>F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 1, p. 147, doi. 10.2967/jnumed.117.193169
- By:
- Publication type:
- Article
Pharmacokinetics, Biodistribution, and Radiation Dosimetry for <sup>89</sup>Zr-Trastuzumab in Patients with Esophagogastric Cancer.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 1, p. 161, doi. 10.2967/jnumed.117.194555
- By:
- Publication type:
- Article
A phase II study of radioimmunotherapy with intraventricular <sup>131</sup> I-3F8 for medulloblastoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prospective Clinical Trial of <sup>18</sup>F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 7, p. 1037, doi. 10.2967/jnumed.116.183335
- By:
- Publication type:
- Article
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC).
- Published in:
- 2017
- By:
- Publication type:
- journal article
First-in-Human Imaging with <sup>89</sup>Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 12, p. 1858, doi. 10.2967/jnumed.116.176206
- By:
- Publication type:
- Article
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using <sup>89</sup>Zr-Trastuzumab PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 10, p. 1523, doi. 10.2967/jnumed.115.172031
- By:
- Publication type:
- Article
Initial Results of a Prospective Clinical Trial of <sup>18</sup>F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 9, p. 1350, doi. 10.2967/jnumed.115.170456
- By:
- Publication type:
- Article
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 274, p. 1, doi. 10.1126/scitranslmed.aaa1009
- By:
- Publication type:
- Article
Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 11, p. 2093, doi. 10.1007/s00259-014-2830-7
- By:
- Publication type:
- Article